Research Report And Analysis: Neuroderm (NASDAQ: NDRM)

NDRM, ABBV

Neuroderm (NDRM), an Israel-based company, is developing next-generation therapies for Parkinson's disease ((PD)). It is the first company to develop liquid form of Levodopa, the first line therapy for the treatment of PD, thus enabling continuous subcutaneous administration of the drug through a...

Neuroderm (NDRM), an Israel-based company, is developing next-generation therapies for Parkinson's disease ((PD)). It is the first company to develop liquid form of Levodopa, the first line therapy for the treatment of PD, thus enabling continuous subcutaneous administration of the drug through a...

This article is only available to subscribers of Vasuda Healthcare Analytics
Learn more about Vasuda Healthcare Analytics